Literature DB >> 27075476

Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.

Laura Lihua Chan1, Choon Pin Lim1, Soe Tin Aung2, Paul Quetua1, Kah Leng Ho1, Daniel Chong1, Wee Siong Teo1, David Sim3, Chi Keong Ching1.   

Abstract

INTRODUCTION: Device therapy is efficacious in preventing sudden cardiac death (SCD) in patients with reduced ejection fraction. However, few who need the device eventually opt to undergo implantation and even fewer reconsider their decisions after deliberation. This is due to many factors, including unresolved patient barriers. This study identified the factors that influenced patients' decision to decline implantable cardioverter defibrillator (ICD) implantation, and those that influenced patients who initially declined an implant to reconsider having one.
METHODS: A single-centre survey was conducted among 240 patients who had heart failure with reduced ejection fraction and met the ICD implantation criteria, but had declined ICD implantation.
RESULTS: Participants who refused ICD implantation were mostly male (84%), Chinese (71%), married (72%), currently employed (54%), and had up to primary or secondary education (78%) and monthly income of < SGD 3,000 (51%). Those who were more likely to reconsider their decision were aware that SCD was a consequence of heart failure with reduced ejection fraction, knowledgeable of the preventive role of ICDs, currently employed and aware that their doctor strongly recommended the implant. Based on multivariate analysis, knowledge of the role of ICDs for primary prophylaxis was the most important factor influencing patient decision.
CONCLUSION: This study identified the demographic and social factors of patients who refused ICD therapy. Knowledge of the role of ICDs in preventing SCD was found to be the strongest marker for reconsidering ICD implantation. Measures to address this information gap may lead to higher rates of ICD implantation. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  barriers; heart failure; implantable cardioverter defibrillator

Mesh:

Year:  2016        PMID: 27075476      PMCID: PMC4853484          DOI: 10.11622/smedj.2016072

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  17 in total

1.  Inequity of use of implantable cardioverter defibrillators in England: retrospective analysis.

Authors:  Julie Parkes; Deborah L Chase; Andrew Grace; David Cunningham; Paul J Roderick
Journal:  BMJ       Date:  2005-02-04

2.  Do some implant too many defibrillators or others too few?

Authors:  Carsten W Israel
Journal:  Europace       Date:  2009-08       Impact factor: 5.214

3.  Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Authors:  Daniel B Mark; Charlotte L Nelson; Kevin J Anstrom; Sana M Al-Khatib; Anastasios A Tsiatis; Patricia A Cowper; Nancy E Clapp-Channing; Linda Davidson-Ray; Jeanne E Poole; George Johnson; Jill Anderson; Kerry L Lee; Gust H Bardy
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

4.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

5.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

6.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

7.  The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial.

Authors:  A I Mushlin; W J Hall; J Zwanziger; E Gajary; M Andrews; R Marron; K H Zou; A J Moss
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

8.  Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation?

Authors:  C J W Borleffs; A A M Wilde; M J M Cramer; E Wever; A Mosterd
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

9.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

10.  Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center.

Authors:  Jason Bradfield; Alberta Warner; Malcolm M Bersohn
Journal:  Pacing Clin Electrophysiol       Date:  2009-03       Impact factor: 1.976

View more
  5 in total

1.  Pan-Asia United States PrEvention of Sudden Cardiac Death Catheter Ablation Trial (PAUSE-SCD): rationale and study design.

Authors:  Minglong Chen; Shulin Wu; Yan Yao; Jian Jiang; Chenyang Jiang; Yumei Xue; Xianzhang Zhan; Hongde Hu; Guosheng Fu; Kai Gu; Hailei Liu; Ligang Ding; Ruhong Jiang; Fa-Po Chung; Yenn-Jiang Lin; Yuichi Hori; Yuki Komatsu; Akiko Ueda; Kyoko Soejima; Young Hoon Kim; Akihiko Nogami; Shiro Nakahara; Shih-Ann Chen; Roderick Tung
Journal:  J Interv Card Electrophysiol       Date:  2019-03-19       Impact factor: 1.900

2.  Patients' knowledge and concerns about using the implantable cardioverter defibrillator for the primary prevention of sudden cardiac death and its correlates: A cross-sectional study.

Authors:  Mohammad A Zakeri; Nadia Sedri; Golamreza Bazmandegan; Maryam Zakeri; Mohammad Safariyan; Mahlagha Dehghan
Journal:  Health Sci Rep       Date:  2022-06-13

3.  Mortality outcome and predictive risk factors for death in patients with heart failure and reduced ejection fraction who declined implantable cardioverter defibrillator implantation in Singapore.

Authors:  Chun Yuan Khoo; John Carson Allen; Shaw Yang Chia; Laura Lihua Chan; Choon Pin Lim; David Sim; Chi Keong Ching
Journal:  J Arrhythm       Date:  2018-08-18

4.  Differences in Characteristics and Outcomes Between Patients With Hypertrophic Cardiomyopathy From Asian and European Centers.

Authors:  Catherina Tjahjadi; Steele C Butcher; Thomas Zegkos; Ching Hui Sia; Kensuke Hirasawa; Vasileios Kamperidis; Jinghao Nicholas Ngiam; Raymond C C Wong; Georgios Efthimiadis; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  J Am Heart Assoc       Date:  2022-05-16       Impact factor: 6.106

5.  Clinicopathological correlates of out-of-hospital cardiac arrests.

Authors:  Tony Li; Jonathan Yap; Wei Qiang Chng; Julian Cheong Kiat Tay; Nur Shahidah; Colin Yeo; Han Nee Gan; Khim Leng Tong; Yih Yng Ng; Jia Hao Wu; Marian Wang; Marcus Eng Hock Ong; Chi Keong Ching
Journal:  J Arrhythm       Date:  2022-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.